BD (NYSE:BDX) announced that it expanded its Class I voluntary recall for its Alaris Pump Module model 8100 infusion system. The expansion builds on a voluntary recall expanded earlier this year, informing customers of worst-case performance instances. Under certain cases, the pump, when used with a subset of compatible infusion sets, fails to perform as […]
BD
BD to invest $35M to expand Nebraska syringe manufacturing
BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe manufacturing. The company expects to add approximately 50 new jobs, expanding the manufacturing at its Columbus, Nebraska, facility. BD says it aims to increase the resiliency of the U.S. healthcare system through its latest syringe manufacturing […]
BD announces first pharma-sponsored clinical trial for wearable injector
BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector technology. The study uses the BD Libertas wearable injector for the subcutaneous delivery of complex biologics. The company said it represents a significant advancement in accelerating innovation in drug-device combination products. It could provide greater flexibility for patients, including potential […]
BD issues voluntary recall on certain Alaris infusion pump modules
BD (NYSE:BDX) announced a voluntary recall related to certain Alaris and Alaris infusion pump modules. Affected Alaris products may have been serviced with previously recalled bezel kit assemblies. BD in 2019 recalled those kit assemblies manufactured between April 2011 and June 2017. They should not be used for service with the Alaris and Alaris Pump […]
BD files patent infringement lawsuit against Baxter over infusion pump tech
BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion pump technology. The company filed its complaint in the U.S. District Court for the District of Delaware on May 12, 2025. BD’s complaint singles out six specific patents: the “180,” “058,” “880,” “868,” “414,” and “703” […]
BD to close infusion and syringe pumps facility in Israel
BD (NYSE: BDX) plans to close a facility in Caesarea, Israel, by the middle of the year. Calcalist’s CTech out of Israel reported the news earlier today, saying that the closure affects 200 employees who will be let go. BD acquired the facility through its 2017 acquisition of Caesarea Medical Electronics, maker of infusion and syringe pumps and accessories for home […]
BD increases U.S. syringe, IV catheter manufacturing
BD (NYSE:BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical medical devices. Those medical devices include syringes, needles and IV catheters. The Franklin Lakes, New Jersey-based company aims to meet the ongoing needs of the nation’s healthcare system. This uptick in manufacturing follows last year’s capacity […]
BD hit with FDA warning related to Pyxis medication management
The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of its $12 billion CareFusion acquisition in 2015. The warning letter, dated Nov. 22 and posted on Dec. 17, involves inspections conducted in May at a former CareFusion facility in San Diego. It notes near […]
BD to pay SEC $175M to settle Alaris investigation
BD (NYSE:BDX) announced that it reached an agreement with the SEC to resolve an investigation related to its Alaris system. The investigation relates to prior public disclosures and SEC reporting regarding Alaris, an infusion pump system. BD neither admits nor denies the findings of an SEC order related to those matters occurring more than four years […]
Ypsomed, BD collab on self-injection systems for high-viscosity biologics
BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance self-injection solutions for high-viscosity biologic drugs. In a joint project, the companies pre-assessed and streamlined the integration of the BD Neopak XtraFlow glass prefillable syringe with the Ypsomed YpsoMate 2.25 auto-injector platform. They aim to address current limitations by enabling the delivery of higher-viscosity […]
